These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9824836)

  • 1. A re-evaluation of the mechanism of action of botulinum toxin on facial movement disorders in man.
    Leon-S FE; Arimura K; Chavez AM
    Med Hypotheses; 1998 Oct; 51(4):305-7. PubMed ID: 9824836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P; Voller B; Moraru K; Auff E
    Wien Klin Wochenschr; 1999 Oct; 111(20):825-9. PubMed ID: 10586486
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin type A injection for hyperfunctional facial lines.
    Keen MS; Khosh MM
    Laryngoscope; 1995 Oct; 105(10):1134-7. PubMed ID: 7564848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Movement disorders and botulinum toxin in neurology].
    Sangla S; Trocello JM; Bourdain F; Vidal JS; Gallouedec G; Vidailhet M
    Ann Readapt Med Phys; 2003 Jul; 46(6):307-11. PubMed ID: 12928135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of botulinum toxin in otorhinolaryngology--experiences and outlook].
    Laskawi R
    Laryngorhinootologie; 1997 Nov; 76(11):656-9. PubMed ID: 9517972
    [No Abstract]   [Full Text] [Related]  

  • 6. Movement, visceral and autonomic disorders: use of botulinum toxin.
    Moore AP
    Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On muscle spindles, dystonia and botulinum toxin.
    Rosales RL; Dressler D
    Eur J Neurol; 2010 Jul; 17 Suppl 1():71-80. PubMed ID: 20590812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the neurologic applications of botulinum toxins.
    Evidente VG; Adler CH
    Curr Neurol Neurosci Rep; 2010 Sep; 10(5):338-44. PubMed ID: 20567945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin in motor disorders: practical considerations with emphasis on interventional neurophysiology.
    Traba López A; Esteban A
    Neurophysiol Clin; 2001 Aug; 31(4):220-9. PubMed ID: 11596529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Dis Mon; 2002 May; 48(5):367-83. PubMed ID: 12195266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current clinical applications of botulinum toxin.
    Truong DD; Stenner A; Reichel G
    Curr Pharm Des; 2009; 15(31):3671-80. PubMed ID: 19925419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changed image of botulinum toxin.
    Misra VP
    BMJ; 2002 Nov; 325(7374):1188. PubMed ID: 12446514
    [No Abstract]   [Full Text] [Related]  

  • 14. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
    Tilton AH
    J Child Neurol; 2003 Sep; 18 Suppl 1():S50-66. PubMed ID: 13677571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myofiber length and three-dimensional localization of NMJs in normal and botulinum toxin treated adult extraocular muscles.
    Harrison AR; Anderson BC; Thompson LV; McLoon LK
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3594-601. PubMed ID: 17652728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution of botulinum toxin to maxillo-facial surgery].
    Batifol D; de Boutray M; Goudot P; Lorenzo S
    Rev Stomatol Chir Maxillofac Chir Orale; 2013 Apr; 114(2):72-8. PubMed ID: 23838244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment outcome with different formulations of botulinum toxin.
    Pérez-Saldaña MT; Tan EK; Burguera JA
    Eur J Neurol; 2009 Mar; 16(3):285-6. PubMed ID: 19364359
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR; Marvaud JC; Raffestin S
    Ann Pharm Fr; 2001 May; 59(3):176-90. PubMed ID: 11427819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the therapeutic use of botulinum toxin in movement disorders.
    Pagni CA
    Ital J Neurol Sci; 1998 Jun; 19(3):189-90. PubMed ID: 10933476
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.